Waldencast (WALD)

• Market cap: $322M
• 1 day: -3.07%
• 5 days: 20.34%
• 1 month: -9.84%
• 3 months: -14.20%
• 6 months: -16.96%
• Year to date: -24.06%
• 1 year: -47.01%
• 5 years: -71.17%
• 10 years: -71.17%
• Sector: Consumer Staples
• Industry: Household & Personal Products

About: Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.

Employees: 332

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

92% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 12

9% more capital invested

Capital invested by funds: $84.9M [Q3] → $92.9M (+$7.94M) [Q4]

8% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 13

0% more funds holding in top 10

Funds holding in top 10: 4 [Q3] → 4 (+0) [Q4]

0.41% less ownership

Funds ownership: 21.04% [Q3] → 20.63% (-0.41%) [Q4]

2% less funds holding

Funds holding: 63 [Q3] → 62 (-1) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $5 76% upside
• Avg. target: $5.83 105% upside
• High target: $7.50 164% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

Alliance Global Partners Aaron Grey 20% 1-year accuracy 1 / 5 met price target	76% upside $5	Buy Initiated	22 Apr 2025
Telsey Advisory Group Dana Telsey 26% 1-year accuracy 47 / 181 met price target	76% upside $5	Outperform Maintained	20 Mar 2025
DA Davidson Linda Bolton Weiser 9% 1-year accuracy 9 / 97 met price target	164% upside $7.50	Buy Maintained	19 Mar 2025